Miv-cel CD19 CAR T-Cell Therapy Shows Efficacy and Safety in Stiff Person Syndrome
Neurology® Podcast
Dr. Shuvro Roy talks with Dr. Amanda L. Piquet about the efficacy and safety of miv-cel in patients with stiff person syndrome. Read more about this abstract on the . Disclosures can be found at .
info_outline
New Resident Guide to Stroke Alerts - Part 2
Neurology® Podcast
In part two of this series, Dr. Andy Southerland talks with Dr. Dan Ackerman about a few rapid‑fire concepts from the 2026 guidelines, focusing on what is new and how emerging data may shape patient care. Disclosures can be found at .
info_outline
New Resident Guide to Stroke Alerts - Part 1
Neurology® Podcast
In part one of this series, Dr. Andy Southerland talks with Dr. Dan Ackerman about the latest guidelines for managing acute ischemic stroke, emphasizing thrombolytic therapy, imaging techniques, and decision-making regarding treatment in extended time windows. Disclosures can be found at .
info_outline
June 2026 Recall: Topics on Parkinsonian Disorders
Neurology® Podcast
The June 2026 Recall highlights four previously posted episodes on parkinsonian disorders. The episode begins with Dr. Valtteri Kaasinen discussing the clinical challenges of diagnosing Parkinson disease and how that diagnosis can evolve over time. The discussion continues with Dr. YuHong Fu, who addresses the importance of differentiating between dementia with Lewy bodies and Parkinson disease dementia. The third episode features Dr. Daniel Weintraub discussing clinical considerations and strategies for effective communication when addressing cognitive concerns in patients with Parkinson...
info_outline
Prion Disease Clinical Trial NN112
Neurology® Podcast
Dr. Gregg Day talks with Drs. Sonia Vallabh and Eric Minikel about scientific insights and the future of prion disease treatment, highlighting the importance of early diagnosis, personalized medicine, and hope for affected families. Learn about the . Learn more about the . Disclosures can be found at .
info_outline
Headache Medicine Highlights from the 2026 AAN Annual Meeting - Part 2
Neurology® Podcast
In the second episode of this series, Dr. Tesha Monteith and Dr. Peter Goadsby continue their conversation on advances in headache medicine, including brain health, migraine as a risk factor for dementia, and future directions in neurology. Disclosures can be found at .
info_outline
Headache Medicine Highlights from the 2026 AAN Annual Meeting - Part 1
Neurology® Podcast
In the first part of this series, Dr. Tesha Monteith talks with Dr. Peter Goadsby about some major themes that emerged from the AAN Annual Meeting regarding headache medicine. Disclosures can be found at .
info_outline
Inflammation, Limbic White Matter, and Symptoms After Repetitive Head Impacts in Retired Football Players
Neurology® Podcast
Dr. Alex Menze talks with Dr. Breton Asken about the long-term impacts of repetitive head impacts in football players, focusing on inflammation, brain microstructure, and cognitive decline. Read the related article in . Disclosures can be found at .
info_outline
Updates Regarding Radiation Necrosis
Neurology® Podcast
Dr. Justin Abbatemarco talks with Dr. Kait Nevel about radiation necrosis following radiation therapy, with a closer look at Boswellia serrata supplement findings. Please read the mentioned in this episode. Disclosures can be found at .
info_outline
Association of Changes in Activity Patterns With Brain Atrophy and Disability Progression in People With MS
Neurology® Podcast
Dr. Alex Menze talks with Dr. Kathryn C. Fitzgerald about using accelerometry to detect subtle, longitudinal changes in disability in people with multiple sclerosis and how these changes relate to brain atrophy and disability progression. Read the related article in . Disclosures can be found at .
info_outlineThe May 2024 replay features four episodes on neuro-oncology for brain cancer awareness month. The episode begins with Dr. Philipp Karschnia discussing the assessment of whether MTHFR polymorphisms affect the risk for leukoencephalopathy. The episode continues with Dr. Ingo Mellinghoff discussing new treatment opinions for isocitrate dehydrogenase (IDH)–mutant grade 2 gliomas. The third interview leads into a conversation with Dr. Linda Liau on the study of vaccine-based therapy for GBM. The episode concludes with Dr. Teddy Totimeh talking about brain tumor programs in Asia and Africa.
Podcast Links:
MTHFR Polymorphisms and Leukoencephalopathy Risk in CNS Lymphoma Patients
New Treatment for IDH mt Gliomas
Study of Vaccine-Based Therapy for GBM
Brain Tumor Programs in Asia and Africa
Article Links:
https://doi.org/10.1212/WNL.0000000000207670
https://www.nejm.org/doi/full/10.1056/NEJMoa2304194
https://jamanetwork.com/journals/jamaoncology/fullarticle/2798847
https://doi.org/10.1016/j.wneu.2023.04.067
Disclosures can be found at Neurology.org.